Lilly's GLP-1 Volume Surge Has a Quiet Infrastructure Beneficiary: **(STVN)**

💡 Today's Spotlight

Eli Lilly reported Q2 results that easily beat estimates and raised its full-year sales outlook, as demand for Zepbound and Mounjaro surged again. The crowd is right to celebrate Lilly — but the durable read-through sits one layer deeper in the supply chain, with the Italian drug-packaging and delivery-systems specialist (STVN). GLP-1 therapies now represent approximately 21–22% of Stevanato's total company revenue , making it structurally downstream of every incremental prescription volume gain Lilly and its peers generate.

The company's momentum reflects strong demand for premium containment and delivery solutions serving complex injectable therapies, including GLP-1 therapies and other advanced treatments. As pharmaceutical customers increasingly seek integrated partners that can combine device innovation, manufacturing expertise, and supply chain reliability , Stevanato's proprietary injector platforms — now receiving European marketing authorizations — position it as a beneficiary of the volume ramp rather than a participant in the pricing war that weighs on branded drug companies.

🔥 Today's Currents — what's new vs steady-state

Buzz

• GLP-1 volume surge supply chain — Lilly Q2 blew past estimates; GLP-1 volume +37% lifts entire supply chain. Exposure: LLY.
• AI power infrastructure funding — Dual $1B rounds for nuclear and battery startups signal AI energy buildout. Exposure: GEV, NEE, VRT.
• labor market softening signals — ADP missed badly; jobs data now the Fed cut timing swing factor. Exposure: SPY, QQQ, IWM.
• defense tech earnings beat — Kratos crushed estimates; defense spending acceleration confirmed. Exposure: KTOS, LHX.
• AI connectivity cloud earnings — Cloudflare reports tonight; agentic AI demand thesis on the line. Exposure: NET, FTNT.

Catalysts

• Challenger Job Cuts · Today 5:30 AM ET · medium impact Prior 45.849.
• Initial Jobless Claims · Today 8:30 AM ET · medium impact Consensus 202 (prior 197). A claims print above 210K would deepen the ADP-driven growth-scare narrative and amplify rate-cut expectations for September.
• Nonfarm Productivity · Today 8:30 AM ET · medium impact Consensus 0.6% (prior 0.3%). A productivity beat paired with soft Unit Labor Costs is the ideal disinflationary combo the Fed needs to validate a cut path.
• Unit Labor Costs · Today 8:30 AM ET · medium impact Consensus 2% (prior 1.8%). Consensus expects 2%; a hot print reignites wage-inflation fears and undermines the Core PCE downtrend that rate-sensitive sectors are pricing.
• Fed's Musalem speech · Today 5:30 PM ET · high impact St. Louis Fed President; his data-dependence framing on sticky YoY core PCE at 3.3% is key for duration and financial-sector positioning.

Sector Watch

• Technology ↑ heating — +29.1% YTD · YTD; AI infrastructure spend accelerating rapidly. Names in focus: NVDA, MSFT, AAPL, AMD.
• Energy ↑ heating — +28.2% YTD · geopolitical squeeze lifting oil prices. Names in focus: XOM, CVX, COP, EOG.
• Real Estate ↓ cooling — +12.0% YTD · XLRE crushed by mortgage rates; financing pressure acute. Names in focus: PLD, AMT, SPG, EQIX.

🏦 Macro & Market Impact

🌐 Overnight tape: Asia lower (Nikkei –0.93%, Hang Seng –1.49%), Europe mixed (FTSE +0.28%), ES futures +0.19%, 10Y 4.63% (–7 bps vs prior close), EUR/USD –0.10%, Brent $80.1.

ADP private payrolls for July came in well below consensus. With

ISM Manufacturing PMI for July beat consensus sharply. The actual print of 55.6 cleared consensus of 54 and marked a meaningful acceleration from June's 53.3, confirming that goods-sector expansion is broadening — a favorable signal for Industrials (XLI, +20.1% YTD) and Materials (XLB, +16.1% YTD) and a counterweight to the soft ADP data in the near-term rate narrative.

ISM Services PMI for July came in just below consensus. The 54.1 print vs. a 54.5 consensus estimate, on top of the ADP miss, is enough for rate markets to reassess the timing of the next Fed cut — the 10Y yield's –7 bps move vs. the prior close reflects exactly this dynamic, compressing the front end and offering incremental relief to duration assets including Real Estate (XLRE, +12.0% YTD).

Core PCE for June undershot consensus. The June actual of 0.1% MoM missed the 0.2% consensus and marked a meaningful deceleration from the prior 0.3%, while the YoY print held exactly in line at 3.3%. The softer MoM print is the single cleanest disinflationary data point of the week and gives the Fed cover to lean dovish —

Fed speakers Musalem and Daly are active today. Both are scheduled to speak Thursday, August 6. With the 10Y already drifting lower and the labor data softening, the market's primary question is whether either speaker validates a September cut or opts to anchor expectations around stubborn YoY core PCE at 3.3%. Any divergence from the consensus "patient" posture moves rate-sensitive names including Financials (XLF, +5.9% YTD) and Utilities (XLU, +2.3% YTD) in opposite directions.

This morning's slate adds further labor-market texture. Initial Jobless Claims (consensus 202K), Nonfarm Productivity (consensus 0.6%), and Unit Labor Costs (consensus 2.0%) are all due at 8:30 AM ET. Together these will either validate or undercut the ADP weakness — Unit Labor Costs in particular are a direct read-through to the inflation persistence debate the Fed is navigating.

📈 Analyst Moves

(PLTR) Deutsche Bank upgraded to Buy from Hold (Aug 4); Northland Securities set a $200 target (Aug 4); Mizuho Securities set a $215 target (Aug 4); Goldman Sachs set a $204 target (Aug 4); 4 other firms set targets spanning $80–$200; 7 firms reiterated.

(KTOS) Piper Sandler upgraded to Overweight from Neutral (Aug 5); Canaccord Genuity set a $135 target (Aug 5); Piper Sandler set a $75 target (Aug 5); Cantor Fitzgerald set a $100 target (Aug 4); 2 firms reiterated.

(TSLA) Stifel Nicolaus set a $491 target (Aug 3); 1 firm reiterated. A target reduction signals concern that near-term execution risk is not yet fully reflected in the premium valuation.

(VRT) Bernstein set a $368 target (Jul 31). A target reduction signals that data-center power density growth, while real, may not sustain the pace of margin expansion the prior target assumed.

(AMZN) Roth Capital set a $325 target (Aug 3); RBC Capital set a $330 target (Jul 31); Deutsche Bank set a $325 target (Jul 31); 7 other firms set targets spanning $310–$390; 20 firms reiterated. A dense cluster of raised targets with wide dispersion in the price points signals broad bullishness tempered by cloud-growth rate uncertainty.

(MSFT) Tigress Financial set a $690 target (Aug 5). A lone but elevated price-target raise signals continued confidence in Azure AI monetization as the primary re-rating driver.

(ALAB) Roth Capital set a $450 target (Aug 5); RBC Capital set a $500 target (Aug 5); UBS set a $425 target (Aug 5); 4 other firms set targets spanning $275–$450; 7 firms reiterated. A broad cluster of sharply raised targets after the earnings beat signals the AI connectivity semiconductor thesis is gaining institutional conviction.

(AMD) D.A. Davidson set a $550 target (Aug 5); Wells Fargo set a $700 target (Aug 5); Morgan Stanley set a $465 target (Aug 5); 4 other firms set targets spanning $594–$650; 7 firms reiterated. The breadth and magnitude of raised targets across multiple firm tiers reflects growing confidence in AMD's data-center GPU share gains.

(AMAT) Goldman Sachs set a $645 target (Aug 3). A single elevated target raise from a top-tier desk underscores sustained conviction in the WFE capex upcycle thesis.

(AAPL) Wells Fargo set a $350 target (Jul 31); Goldman Sachs set a $360 target (Jul 31); Barclays set a $245 target (Jul 31); 9 firms reiterated. Simultaneous target reductions from multiple top-tier desks signal persistent concern around iPhone demand and Services growth deceleration.

(CI) Jefferies set a $307 target (Aug 4); Raymond James set a $320 target (Aug 3); Robert W. Baird set a $362 target (Jul 31); 2 other firms set targets spanning $307–$361; 3 firms reiterated.

(XOM) HSBC set a $158 target (Aug 3); Wells Fargo set a $182 target (Aug 3). Divergent targets from two firms reflects genuine disagreement on oil price trajectory and refining spread assumptions.

(VLO) Mizuho Securities set a $300 target (Aug 4); UBS set a $355 target (Jul 31); Wells Fargo set a $356 target (Jul 31); 1 other firm set targets at $323; 3 firms reiterated. A cluster of raised targets from energy-specialist desks reflects confidence in refining margin durability through year-end.

(ARM) Rosenblatt Securities set a $250 target (Jul 31); 1 firm reiterated. A target reduction flags concern that the current multiple leaves limited margin for any miss on royalty ramp expectations.

(NET) Jefferies set a $290 target (Aug 4); Cantor Fitzgerald set a $250 target (Aug 3). Target raises heading into tonight's print reflect optimism around AI-driven demand acceleration in the connectivity cloud.

(BAC) UBS set a $70 target (Aug 3). A target raise from a major bank signals improving confidence in net interest income trajectory as the rate path clarifies.

(GS) UBS set a $1150 target (Aug 3). A target raise to a notably elevated level reflects the investment banking and advisory revenue recovery being priced further out.

(JPM) UBS set a $400 target (Aug 3). A target raise to a high absolute level reflects consensus that JPM's diversified model outperforms peers in a late-cycle environment.

(FTNT) Susquehanna set a $160 target (Jul 31); 1 firm reiterated. A maintained target rather than a raise suggests the analyst sees the current setup as fairly valued relative to cybersecurity peers.

1 name saw reiterations only (no rating change or new target): (LHX).

This section covers watchlist names only; analyst moves on non-watchlist stocks may have occurred but are not tracked here.

💼 Capital Flow & Strategy

Valar Atomics and Base Power each closed $1 billion private rounds this week, both explicitly tied to powering AI workloads, per Tech Startups reporting. A $1 billion Series B for Valar Atomics and a $1 billion Series D for Base Power — both tied to powering AI workloads — underscored that big bets in AI, energy infrastructure, and next-generation security are dominating capital flows. The direct read-through for watchlist names is concentrated in the power-and-grid value chain: (GEV) and (NEE) sit structurally upstream of the data-center buildout these rounds are designed to serve, and sustained private-market conviction at the $1B+ level validates the long-cycle capex thesis already embedded in Industrials (XLI, +20.1% YTD).

Biopharma M&A and licensing activity remained elevated throughout H1 2026, per J.P. Morgan's Biopharma and Medtech Deal Report. Biopharma licensing announced R&D value reached $166.7 billion in H1 2026, while M&A totaled $96 billion across 80 deals for the half, per J.P. Morgan's report powered by DealForma. The pace reflects both cash-rich balance sheets and a strategic urgency to acquire pipeline — a structural tailwind for deal advisory franchises at (GS), (JPM), and (BAC), whose Health Care (XLV, +6.0% YTD) sector banking units are active in this cycle.

📅 Earnings This Week

(PLTR) Palantir Technologies, reported Monday, August 3 — EPS $0.41 vs $0.34 consensus; revenue $1.9B vs $1.8B expected. The beat validates AI-software monetization and directly lifts sentiment across the government and commercial analytics space, with read-through to the broader enterprise AI adoption thesis.

(ALAB) Astera Labs, reported Tuesday, August 4 — EPS $0.80 vs $0.69 consensus; revenue $392M vs $361M expected. A clean beat underscoring robust demand for AI connectivity silicon, with direct read-through to the broader semi-infrastructure chain including (NVDA), (AMD), and (AVGO).

(AMD) Advanced Micro Devices, reported Tuesday, August 4 — EPS $1.66 vs $1.62 consensus; revenue $11.5B vs $11.3B expected. The beat signals continued GPU and data-center momentum, reinforcing the AI hardware super-cycle thesis with read-through to (AMAT), (MU), and (TSM).

(KTOS) Kratos Defense & Security Solutions, reported Tuesday, August 4 — EPS $0.21 vs $0.14 consensus; revenue $459M vs $410M expected. A substantial beat across both lines signals defense spending acceleration, with read-through to (LHX) and the broader defense technology complex.

(LLY) Eli Lilly, reported Wednesday, August 5 — EPS $8.38 vs $6.28 consensus; revenue $23.0B vs $20.7B expected. Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from previous guidance of $82 billion to $85 billion. The blockbuster beat and guidance raise is the week's dominant fundamental event, with read-through to the entire GLP-1 supply chain, drug-delivery infrastructure, and Health Care (XLV, +6.0% YTD).

(NET) Cloudflare, Thursday, August 6 — consensus EPS $0.27, revenue est $665M. Cloudflare will report its Q2 results after the U.S. market closes today, Thursday, August 6, 2026. The print tests the agentic-AI and connectivity-cloud demand thesis; Cloudflare's restructuring toward an AI-first architecture makes the commentary on enterprise pipeline as important as the revenue line itself.

Tier 2 — Notable large-cap reporters:

(CAT) Caterpillar, reported Tuesday, August 4 — EPS $8.17 vs $6.22 consensus; revenue $20.5B vs $19.3B expected. A decisive beat from the global infrastructure bellwether confirms heavy-equipment demand remains robust, supporting the Industrials (XLI) thesis.

(DIS) Walt Disney, reported Wednesday, August 5 — EPS $2.06 vs $1.86 consensus; revenue $25.2B vs $25.4B expected. The EPS beat offset a modest revenue miss; streaming and parks execution remain the core narrative.

(CVS) CVS Health, reported Wednesday, August 5 — EPS $2.58 vs $1.87 consensus; revenue $106.1B vs $100.0B expected. A sizeable beat on both lines at the pharmacy and insurance conglomerate; read-through to managed-care sentiment broadly.

Tier 3 — Under-the-radar read-throughs:

(MCK) McKesson, reported Wednesday, August 5 — EPS $9.93 vs $9.56 consensus; revenue $105.4B vs $103.9B expected. McKesson is a primary pharmaceutical distributor and a direct downstream beneficiary of accelerating GLP-1 prescription volumes, making its beat a confirmatory signal for the (LLY) demand thesis.

(PSX) Phillips 66, reported Wednesday, August 5 — EPS $9.41 vs $7.50 consensus; revenue $52.0B vs $43.6B expected. A refining bellwether with direct read-through to (VLO) margin dynamics and the Energy (XLE, +28.2% YTD) sector's earnings trajectory.

---

📅 See the full week's market calendar → thefirsttick.com/calendar

The author may hold positions in securities discussed in this Brief. The author does not trade any security discussed within 48 hours before or after publication. See the Position Policy at thefirsttick.com/position-policy.

For informational and educational purposes only. Not financial advice or a recommendation to buy, sell, or hold any security. Past performance does not guarantee future results. Consult a licensed financial advisor for personalized advice.